CLINICAL TRIAL OF A NEW HYPOTENSIVE DRUG, METHYLDOPA (“ALDOMET”)
- 1 July 1962
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 2 (2), 52-55
- https://doi.org/10.5694/j.1326-5377.1962.tb19971.x
Abstract
Click on the article title to read more.This publication has 15 references indexed in Scilit:
- ALPHA METHYL DOPA IN TREATMENT OF HYPERTENSIONThe Lancet, 1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Decarboxylase inhibitors in the treatment of hypertension∗The American Journal of Cardiology, 1962
- Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopaThe American Journal of Cardiology, 1962
- ON CURRENT STATUS OF SEROTONIN AS A BRAIN NEUROHORMONE AND IN ACTION OF RESERPINELIKE DRUGSAnnals of the New York Academy of Sciences, 1962
- Actions of the Decarboxylase Inhibitor, α-Methyl-3,4-dihydroxyphenylalanine, in the DogNature, 1960
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- NEWER BIOCHEMICAL APPROACHES TO THE TREATMENT OF HYPERTENSIONAnnals of the New York Academy of Sciences, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- THE PHARMACOLOGICAL ACTIONS OF 3,4‐DIHYDROXY‐PHENYL‐α‐METHYLALANINE (α‐METHYLDOPA), AN INHIBITOR OF 5‐HYDROXYTRYPTOPHAN DECARBOXYLASEBritish Journal of Pharmacology and Chemotherapy, 1960